Crisaborole for treating mild to moderate atopic dermatitis in people aged 2 years and older – appraisal consultation

In DRAFT guidance, NICE does not recommend crisaborole for treating mild to moderate atopic dermatitis in people ≥2 yrs when 40% or less of their body surface area is affected, as there is uncertainty about any clinical benefits (cost-effectiveness analysis therefore unreliable).

Source:

National Institute for Health and Care Excellence